Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >API >Antineoplastic agents >Other antineoplastic Drugs >Lonidamine

Lonidamine

Lonidamine Structure
  • ₹11409.55 - ₹139059
  • Product name: Lonidamine
  • CAS: 50264-69-2
  • MF: C15H10Cl2N2O2
  • MW: 321.16
  • EINECS:256-510-0
  • MDL Number:MFCD00866285
  • Synonyms:af1890 ;1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid;1H-Indazole-3-carboxylicacid, 1-[(2,4-dichlorophenyl)Methyl]-;1-(2,4-dichlorbenzyl)-indazole-3-carboxylicacid ;1-(2,4-dichlorobenzyl)-1h-indazole-3-carboxylicaci ;Lonidamine, >=99%;1-(3,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid;DICLONDAZOLIC ACID
4 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)
  • ottokemi

Package

  • 5MG
  • 25MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberL4900
  • Product descriptionLonidamine mitochondrial hexokinase inhibitor
  • Packaging5MG
  • Price₹11409.55
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberL4900
  • Product descriptionLonidamine mitochondrial hexokinase inhibitor
  • Packaging25MG
  • Price₹50217.18
  • Updated2022-06-14
  • Buy
  • Manufacturerottokemi
  • Product number L 3912
  • Product descriptionLonidamine
  • Packaging5mg
  • Price₹39069
  • Updated2022-05-26
  • Buy
  • Manufacturerottokemi
  • Product number L 3912
  • Product descriptionLonidamine
  • Packaging25mg
  • Price₹139059
  • Updated2022-05-26
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) L4900 Lonidamine mitochondrial hexokinase inhibitor 5MG ₹11409.55 2022-06-14 Buy
Sigma-Aldrich(India) L4900 Lonidamine mitochondrial hexokinase inhibitor 25MG ₹50217.18 2022-06-14 Buy
ottokemi L 3912 Lonidamine 5mg ₹39069 2022-05-26 Buy
ottokemi L 3912 Lonidamine 25mg ₹139059 2022-05-26 Buy

Properties

Melting point :207-209°C
Boiling point :537.9±45.0 °C(Predicted)
Density :1.4835 (rough estimate)
refractive index :1.6070 (estimate)
storage temp. :Sealed in dry,2-8°C
solubility :Soluble in DMSO (up to 25 mg/ml).
form :solid
pka :3.00±0.10(Predicted)
color :White
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
InChIKey :WDRYRZXSPDWGEB-UHFFFAOYSA-N
CAS DataBase Reference :50264-69-2(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS hazard pictogramsGHS hazard pictograms
Signal word: Danger
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning GHS hazard pictograms P264, P270, P301+P312, P330, P501
H351 Suspected of causing cancer Carcinogenicity Category 2 Warning P201, P202, P281, P308+P313, P405,P501
H360 May damage fertility or the unborn child Reproductive toxicity Category 1A, 1B Danger GHS hazard pictograms
Precautionary statements:
P201 Obtain special instructions before use.
P308+P313 IF exposed or concerned: Get medical advice/attention.

Description

Lonidamine is a derivative of indazole-3-carboxylic acid. It is a kind of orally administrated small molecule, which can inhibit the glycolysis process through inactivating the hexokinase (the first step in glycolysis). It has been shown that cancer cell primarily generates energy through glycolysis process. Therefore, Lonidamine has been used for the treatment of several kinds of cancers. One special property of Lonidamine is that it seems to enhance aerobic glycolysis in normal cells, but inhibit glycolysis only in cancer cells. In addition, there are also evidences that Lonidamine may increase the occurrence of apoptosis. It has also been shown that Lonidamine is effective in the treatment of benigh prostatic hyperplasia (BPH).

Related product price